Sickle cell disease is a multisystem disorder caused by a single gene mutation in the beta globin gene. Sickle cell disease has a challenging disease course, with the 2 hallmark symptoms being hemolytic anemia and vaso-occlusion. Pain crisis is the most common reason for seeking treatment, and these pain episodes are associated with significant hospital admissions and negatively impact quality of life. In recent years, several novel therapies have been approved for the management of sickle cell disease, and several additional drugs are currently under development.
The learning objectives of this program are:
Friday, December 10, 2021
Registration and Brunch: 10:15 AM – 11:00 AM EST
Scientific Session: 11:00 AM – 1:30 PM EST
Hyatt Regency Atlanta
In-Person and Live Streaming